G-AGMATINE
LIVE

Serial Number

85063392

Owner

Gilad Gad M

First Use Date

Jan 27, 2010

Filing Date

Jun 15, 2010

Add to watchlist:

No watchlists yet
View on USPTO

G-AGMATINE Trademark

Serial Number: 85063392 • Registration: 3913801

G-AGMATINE is a trademark filed by Gilad Gad M on June 15, 2010. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Gilad Gad M (3 trademarks)

Henderson, NV 89015

Entity Type: 01

Gilad Varda (6 trademarks)

Henderson, NV 89015

Entity Type: 01

Trademark Details

Filing Date

June 15, 2010

Registration Date

February 1, 2011

First Use Anywhere

January 27, 2010

First Use in Commerce

January 27, 2010

Published for Opposition

November 16, 2010

Goods & Services

Animal feed supplements; Dietary and nutritional supplements; Dietary and nutritionally fortified food products adapted for medical use; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary pet supplements in the form of pet treats; Dietary supplements; Dietary supplements for animals; Dietary supplements for pets; Dietary supplements for pets in the nature of a powdered drink mix; Food supplements; Foods for individuals with special dietary requirements necessitated by medical treatments; Health food supplements; Homeopathic supplements; Medicated supplements for foodstuffs for animals; Natural supplements for treating depression and anxiety; Nutraceuticals for use as a dietary supplement; Nutritional additives for medical purposes for use in foods and dietary supplements for human consumption; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplements; Nutritional supplements in capsule form for dogs; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations namely, antidepressants

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Nov 3, 2020 NA89
HIDDEN SENSITIVE CONTENT
Nov 3, 2020 HSCD
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Nov 3, 2020 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Nov 3, 2020 89AG
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Oct 31, 2020 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Oct 26, 2020 PR89
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 25, 2020 APRE
TEAS SECTION 8 & 9 RECEIVED
Oct 20, 2020 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 1, 2020 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 23, 2016 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 23, 2016 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 23, 2016 APRE
TEAS SECTION 8 & 15 RECEIVED
Jul 17, 2016 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 17, 2016 TCCA
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 1, 2016 REM1
REGISTERED-PRINCIPAL REGISTER
Feb 1, 2011 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 16, 2010 NPUB
PUBLISHED FOR OPPOSITION
Nov 16, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 8, 2010 PREV
ASSIGNED TO LIE
Oct 8, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 23, 2010 CNSA
ASSIGNED TO EXAMINER
Sep 23, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 18, 2010 NWOS
NEW APPLICATION ENTERED
Jun 18, 2010 NWAP